JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia	B-ALL; B-NHL	Recruiting	Not applicable	2024-11-07		NCT06678282

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Shenzhen Genocury Biotech Co., Ltd.	4

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Zhengzhou University	Zhenzhou	China	3

Clinical trials